Executive Director Cliff Dacso's Op-Ed on the conundrum of quality assessment in health care. How do we judge and compare individual doctors in a way that is fair and makes sense to patients? Read the article.
New Info-Gap Website
A new website has been published on the decision theory developed by Center partner researcher Yakov Ben-Haim, PhD, of the Technion-Israel Institue of Technology. Info-gap is a method for analysis, planning, decision and design under uncertainty. Visit the website.
The Future of Medicine 2020: Texas-United Kingdom Collaborative
In November, Center Executive Director Dr. Cliff Dacso presented at the 3rd Technology Innovation Forum, "The Future Delivery of Medicine: 2020." The forum was held at University College, London and co-hosted by the TX-UK Collaborative and UCL Advances. The workshop gathered together international experts in research, engineering and policy to discuss pressing issues in health delivery.
Dr. Dacso's presentation was entitled “Extension Technologies in Developed and Developing Economies.” Center researcher Nithin Rajan spoke on “Lessons Learned from Blue Box Device Development.”
2008 APHA Presentations
Four Center researchers were invited to speak at the 136th Annual Meeting of the American Public Health Association in San Diego, October 25-29. Courtney Queen, PhD, spoke on access to healthcare by the uninsured, Amalia Issa, PhD, MPH, spoke on translating advances in personalized medicine to population health and moderated a session on genomic medicine. Nithin Rajan and Amy Harris, MPH, presented the Center's interactive website for newly diagnosed localized prostate cancer patients.
Center, Rice University Receive $1.5 million Grant
The Abramson Center, Rice University, and Technology For All (TFA) have received a $1.5 million National Science Foundation grant for research in east Houston that will examine ways to provide novel, health-sensing applications using a new generation of low cost wireless networks and mobile computing platforms.
LEARN MORE by listening to a KUHF interview with the Center's Executive Director, Dr. Cliff Dacso. The interview is also available on the KUHF website.
David Watts, MD, Gives Fourth Annual Gregory Lecture
On November 4, David Watts, MD presented "Professionalism in Medicine, Finding the Balance" at the Fourth Annual Lloyd Gregory, Jr, MD Lecture in Medical Professionalism. The lecture series honors the legacy of Dr. Gregory, former Medical Director of the Dunn Foundation. Dr. Watts is professor of medicine at the University of California San Francisco, and an NPR commentator.
Dacso Featured on Science & Society
Each week, SCIENCE AND SOCIETY presents interviews with trendsetting and groundbreaking researchers, industry-leading executives, and senior government officials, providing in-depth coverage of the publication's core areas. Listen to the podcast of the interview with Cliff Dacso, MD.
Issa Awarded Greenwall Foundation Grant
Amalia Issa, PhD, Director of Personalized Medicine and Targeted Therapeutics for the Center, received a grant for over $100,000 from the Greenwall Foundation. The grant, entitled "Evaluating Patient Decision-Making and Preferences for Personalized Medicine," will support her analysis of patient preferences and trade-offs as they make decisions about genetically tailored treatments.
Dacso Receives Second National Science Foundation Award
Center Executive Director Dr. Clifford Dacso received his second National Science Foundation grant this month. With our co-investigators at Rice University, headed by Dr. Ashutosh Sabharwal, the Center will share in an award of $2 million over 4 years. This award is for continued development of biosensors for use in under-resourced communities.
Center Members Present at International Meetings
Yakov Ben-Haim, PhD; Clifford Dacso, MD; Jon Carrasco; and Nithin Rajan presented a research poster entitled "Robust-Satisficing Decision Making Under Severe Uncertainty Illuminates Patient Choice" at the 28th Annual Meeting of the Society for Medical Decision Making, October 14-18 in Boston.
On October 10, Amalia Issa, PhD, spoke on "The Role of Pharmacogenomics in Drug Development: Economic and Regulatory Considerations" at the 56th Annual Meeting of the American Society for Human Genomics in New Orleans.
